Literature DB >> 19525381

Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.

Richard A Fenton1, Satoshi Komatsu, Mitsuo Ikebe, Lynne G Shea, James G Dobson.   

Abstract

Adenosine protects the heart from adrenergic overstimulation. This adenoprotection includes the direct anti-adrenergic action via adenosine A(1) receptors (A(1)R) on the adrenergic signaling pathway. An indirect A(1)R-induced attenuation of adrenergic responsiveness involves the translocation of PKC-epsilon to t-tubules and Z-line of cardiomyocytes. We investigated with sarcomere imaging, immunocytochemistry imaging, and coimmunoprecipitation (co-IP) whether A(1)R activation of PKC-epsilon induces the kinase translocation to receptor for activated C kinase 2 (RACK2) in isolated rat and mouse hearts and whether phospholipase C (PLC) is involved. Rat cardiomyocytes were treated with the A(1)R agonist chlorocyclopentyladenosine (CCPA) and exposed to primary PKC-epsilon and RACK2 antibodies with secondaries conjugated to Cy3 and Cy5 (indodicarbocyanine), respectively. Scanning confocal microscopy showed that CCPA caused PKC-epsilon to reversibly colocalize with RACK2 within 3 min. Additionally, rat and mouse hearts were perfused and stimulated with CCPA or phenylisopropyladenosine to activate A(1)R, or with phorbol 12-myristate 13-acetate to activate PKC. RACK2 was immunoprecipitated from heart extracts and resolved with SDS-PAGE. Western blotting showed that CCPA, phenylisopropyladenosine, and phorbol 12-myristate 13-acetate in the rat heart increased the PKC-epsilon co-IP with RACK2 by 186, 49, and >1,000%, respectively. The A(1)R antagonist 8-cyclopentyl-1,3-dipropylxanthine prevented the CCPA-induced co-IP with RACK2. In mouse hearts, CCPA increased the co-IP of PKC-epsilon with RACK2 by 61%. With rat cardiomyocytes, the beta-adrenergic agonist isoproterenol increased sarcomere shortening by 177%. CCPA reduced this response by 47%, an action inhibited by the PLC inhibitor U-73122 and 8-cyclopentyl-1,3-dipropylxanthine. In conclusion, A(1)R stimulation of the heart is associated with PLC-initiated PKC-epsilon translocation and association with RACK2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525381      PMCID: PMC2724201          DOI: 10.1152/ajpheart.00247.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

Review 1.  Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

Authors:  T J Kamp; J W Hell
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

Review 2.  Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions.

Authors:  A C Newton
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

Review 3.  Intracellular transport mechanisms of signal transducers.

Authors:  Gerald W Dorn; Daria Mochly-Rosen
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 4.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

5.  Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.

Authors:  M Parsons; L Young; J E Lee; K A Jacobson; B T Liang
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

6.  Chronic ethanol enhances adenosine antiadrenergic actions in the isolated rat heart.

Authors:  R A Fenton ; E S Chung
Journal:  Alcohol Clin Exp Res       Date:  2001-07       Impact factor: 3.455

7.  Role for PKC in the adenosine-induced decrease in shortening velocity of rat ventricular myocytes.

Authors:  J W Lester; P A Hofmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

8.  PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression.

Authors:  J M Pass; Y Zheng; W B Wead; J Zhang; R C Li; R Bolli; P Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

Review 9.  Catecholamine cardiotoxicity.

Authors:  G Rona
Journal:  J Mol Cell Cardiol       Date:  1985-04       Impact factor: 5.000

10.  Adenosine A1 and A2A receptor regulation of protein phosphatase 2A in the murine heart.

Authors:  Eugene I Tikh; Richard A Fenton; Jiang-Fan Chen; Michael A Schwarzschild; James G Dobson
Journal:  J Cell Physiol       Date:  2008-07       Impact factor: 6.384

View more
  6 in total

1.  Reduced adenosine release from the aged mammalian heart.

Authors:  Richard A Fenton; James G Dobson
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

2.  Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27.

Authors:  Richard A Fenton; Lynne G Shea; Cecilia Doddi; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

3.  Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes.

Authors:  Satoshi Komatsu; James G Dobson; Mitsuo Ikebe; Lynne G Shea; Richard A Fenton
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

4.  Protein kinase Cɛ activity regulates mGluR5 surface expression in the rat nucleus accumbens.

Authors:  Marek Schwendt; M Foster Olive
Journal:  J Neurosci Res       Date:  2016-08-21       Impact factor: 4.164

5.  ARF1-regulated coatomer directs the steady-state localization of protein kinase C epsilon at the Golgi apparatus.

Authors:  Tabitha A Peterson; Mark Stamnes
Journal:  Biochim Biophys Acta       Date:  2012-11-27

6.  Thienoquinolines as novel disruptors of the PKCε/RACK2 protein-protein interaction.

Authors:  Florian Rechfeld; Peter Gruber; Johannes Kirchmair; Markus Boehler; Nina Hauser; Georg Hechenberger; Dorota Garczarczyk; Gennady B Lapa; Maria N Preobrazhenskaya; Peter Goekjian; Thierry Langer; Johann Hofmann
Journal:  J Med Chem       Date:  2014-04-08       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.